Breast Cancer Optical Method for Faster, More Accurate Diagnosis of Breast Cancer By article A new optical method for more quickly and accurately determining whether breast tissue lesions are cancerous is described by University … Read More→
_ Breast Cancer Ovarian Cancer Hereditary Breast and Ovarian Cancers: Moving Toward More Precise Prevention By article By NIH Director Francis Collins, M.D., Ph.D. Inherited mutations in the BRCA1 gene and closely related BRCA2 gene account for … Read More→
_ Breast Cancer Breast Screening Over Age 70 May Lead to Overdiagnosis By article Mammograms for women over the age of 70 s doesn’t prompt a sharp fall in advanced disease and may instead … Read More→
_ Breast Cancer Scientists Zeroing In on Third Breast-Cancer Gene By Jane Farrell article Researchers have discovered more about a breast-cancer gene that could be as important as the BRCA1 and BRCA2 mutations in determining a womanΓÇÖs likelihood of getting breast cancer. An international team of 17 researchers, led by the University of Cambridge, said that the gene, PALB 2, could be a candidate to be ΓÇ£BRCA 3.ΓÇ¥ They said that women with the gene have an average one in three chance of developing breast cancer by the age of 70. The findings were reported in the New England Journal of Medicine. Although itΓÇÖs been known for a while that PALB2 was l
_ Breast Cancer Exposure To Nighttime Light Could Be Dangerous for Breast-Cancer Patients By Jane Farrell article The breast-cancer drug tamoxifen is useless if a patient is exposed to even dim overnight light, according to a new study. But it can become effective during the same period in combination with the hormone melatonin. Researchers from Tulane University School of Medicine published the study in the journal Cancer Research. It is the first study to show that melatonin, which regulates sleep and wake cycles, is essential to tamoxifenΓÇÖs success in treating breast cancer. But melatonin doesnΓÇÖt work if itΓÇÖs shut off by exposure to light at night.
_ Breast Cancer Many Elderly BC Patients Are Taking Hormone Therapy By Jane Farrell article Women over 65 with non-metastatic breast cancer are likely to follow recommendations for preventive hormone treatment. But non-white women were much less likely to have that therapy. The women who had the therapy suffered from estrogen-positive breast cancer and were given either an aromatase inhibitor or tamoxifen. Those hormones prevent tumors from using estrogen to fuel growth. The study was reported in the Journal of Clinical Oncology.
Breast Cancer A Possible Link Between Carbohydrates and Breast Cancer By Jane Farrell article Limiting carbohydrate intake could reduce the risk of one type of breast cancer, researchers have found. The findings, published in the journal Cancer Epidemiology Biomarkers & Prevention, focused on the cancer whose tumor tissue has the IGF-1 receptor. "There is a growing body of research demonstrating associations between obesity, diabetes, and cancer risk," said lead author Jennifer A. Emond, an instructor in the Department of Community and Family Medicine at the Geisel School of Medicine at Dartmouth College.
_ Breast Cancer Breast Cancer and Malfunctioning Cells in Older Women By Jane Farrell article Scientists are a step closer to understanding why older women are more susceptible to breast cancer. Researchers from the Department of EnergyΓÇÖs Lawrence Berkeley National Laboratory (Berkeley Lab) said their study shows that as women age, cells that that are responsible for maintaining healthy breast stop responding to cues that should prompt them to suppress nearby tumors. According to the National Cancer Institute, breast cancer is most frequently diagnosed among women aged 55 to 64.
_ Breast Cancer Chemotherapy and Hospitalization By Jane Farrell article Scientists have zeroed in on which chemotherapy regiments are likelier to lead to hospitalizations for early stage breast cancer patients. The retrospective study, published in the Journal of Clinical Oncology, was conducted by researchers from the University of Texas MD Anderson Cancer Center. For their analysis, the researchers looked at hospitalization-related insurance claims by patients who were undergoing varying chemotherapy regimens.
_ Breast Cancer Hope for Beating HER2-Positive Breast Cancer By article Scientists at Cold Spring Harbor Laboratory on Lonf Island in New York report on May 18th 2014 a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer commonly called "HER2-positive".
_ Breast Cancer Misguided Fear of Radiation from Mammograms By article Misinformation and misunderstanding about the risks associated with ionizing radiation have created heightened public concern and fear that may result in women avoiding mammograms that can detect early cancers, according to the American Roentgen Ray Society(ARRS), a radiology society was founded in 1900 in Leesburg, VA.
_ Breast Cancer Sleeping Well Boosts Survival for Breast Ca Patients By article A study done at Stanford and published in the May 1st 2014 issue of the journal Sleep reports that “sleep efficiency”, defined as the ratio of time asleep to time spent in bed, is predictor of survival time for women with advanced breast cancer.
_ Breast Cancer Chemo for Breast Ca May Lead to Job Loss By article A study done at the University of Michigan Health System has found that loss of paid employment after a diagnosis of early-stage breast cancer may be common and potentially related to the type of treatment patients received. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings support efforts to reduce the side effects and burden of treatments for breast cancer and to identify patients who may forego certain treatments, particularly when the expected benefit is low.
_ Breast Cancer Study: Chemotherapy Not Always Best for Breast Cancer By Jane Farrell article Although many women with early-stage breast cancer are getting chemotherapy, the ones that decide against it appear to be more empowered about making a good decision, new research indicates. The current guidelines for treating cancer that hasn’t spread to the lymph nodes or other parts of the body have led to thousands of women receiving chemotherapy without benefiting from it.
_ Breast Cancer Doubling ΓÇ£Progression-Free SurvivalΓÇ¥ of Breast Ca Patients By article The amount of time patients with hormone-receptor–positive breast cancer were on treatment without their cancer worsening, which is called "progression-free survival", was effectively doubled in women with advanced breast cancer who took the experimental drug palbociclib. That was the result of the final clinical trials conducted by researchers from the Revlon/UCLA Women's Cancer Research Program at Jonsson Comprehensive Cancer Center on the campus of the University of California, Los Angeles.
_ Breast Cancer Hope For Treating A Deadly Breast-Cancer Gene By Jane Farrell article Researchers have discovered that a gene, previously not linked to breast cancer, plays a central role in the growth of triple negative breast cancer. Targeting that gene, the research indicates, could lead to a new approach for treating that form of the disease. Triple negative breast cancer, which accounts for 20 percent of all breast cancer cases, often has few treatment options.
Breast Cancer Breast Reconstruction: Making the Decision By Jane Farrell article Every woman who has a mastectomy is then faced with another choice: whether to have breast reconstruction – surgery to rebuild the shape of the breast. There are other choices, according to the National Cancer Institute (NCI): to wear a breast form, or padding, or to do nothing.
Breast Cancer Mammogram Risks for Age 70+ Outweigh Benefits By article Researchers from Leiden University Medical Centre in The Netherlands report that their study suggests that breast cancer screening programs for older women results in a large proportion of women being over-treated, and at risk from the harmful effects of such treatment, because these women were more likely to die from other causes than from any tumors detected in the early stages of growth. The team presented the findings the European Breast Cancer Conference in Glascow UK.